Wednesday, February 10, 2010, 4:57am EST - Canadian Markets open in 4 hours and 33 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Clarient, Inc. (CLRT)

 On Feb 9: 2.16 USD   0.00 (0.00%)  
MORE ON CLRT
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Clarient, Inc. (NCM:CLRT) Delayed quote dataEdit
Last Trade: 2.16 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 2.16
Open: N/A
Bid: N/A
Ask: 2.45 x 500
1y Target Est: 4.25
Day's Range: N/A - N/A
52wk Range: 1.45 - 4.43
Volume: 0
Avg Vol (3m): 531,333
Market Cap: 169.40M
P/E (ttm): N/A
EPS (ttm): -0.11
Div & Yield: N/A (N/A%)
Clarient, Inc. (CLRT)
1d  5d  3m  6m  1y  2y  5y  max 
 Add CLRT to Portfolio   Download Data

HEADLINES
• Clarient CEO Ron Andrews to Present at the UBS 20th Annual Global Healthcare Services Conference in New York City
PRNewswire (Thu, Feb 4)
• Clarient CEO Ron Andrews to Present at Jefferies 2010 Global Healthcare Services Conference in New York City
PRNewswire (Wed, Jan 20)
• Coverage initiated on Clarient by ThinkEquity
Briefing.com (Fri, Jan 8)
• Clarient CEO Ron Andrews to Present at J.P. Morgan 28th Annual Healthcare Conference in San Francisco
PRNewswire (Wed, Jan 6)
• CLARIENT, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio
EDGAR Online (Wed, Dec 23)
• Stocks on the Move: Boeing, ConAgra, Jabil Circuit
at BusinessWeek (Wed, Dec 23)
• Clarient buys cancer test maker Applied Genomics
AP (Mon, Dec 21)
• Clarient Acquires Applied Genomics, Inc.
PRNewswire (Mon, Dec 21)
• Health Care Companies With Wide Coverage Reach In Certain States Will Benefit Greatly From The $400 Billion To Be Spent By Medicaid
Wall Street Transcript (Mon, Dec 14)
• Clarient, Celldex: Early Volume Plays
at TheStreet.com (Mon, Dec 14)
More Headlines for CLRT...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Clarient, Inc. operates as an oncology diagnostics services company in the United States. It provides cellular assessment and cancer characterization to community pathologists, academic researchers and university hospitals, and bio pharmaceutical ...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices